In addition, the role of mutations or deactivation of tumor suppressor genes, including P53 and phosphatase and tensin homolog (PTEN) are being explored.97,99–101 In the past decade, only a few metabolism-based cancer drugs have been successfully developed, some of which are in or nearing clinical trials. This evidence concerns the gene PTEN and cancer.